about
Decreasing Distortion Energies without Strain: Diazo-Selective 1,3-Dipolar CycloadditionsSwitchable polarity solvent (SPS) systems: probing solvatoswitching with a spiropyran (SP)-merocyanine (MC) photoswitch.A complex with nitrogen single, double, and triple bonds to the same chromium atom: synthesis, structure, and reactivity.Asymmetric, stereodivergent synthesis of (-)-clusianone utilizing a biomimetic cationic cyclizationTwisted amide electrophiles enable cyclic peptide sequencing.Three-component glycolate Michael reactions of enolates, silyl glyoxylates, and α,β-enonesSultones and Sultines via a Julia-Kocienski Reaction of EpoxidesFast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity.Hydrogen-abstraction reactivity patterns from A to Y: the valence bond way.A propos of glycosyl cations and the mechanism of chemical glycosylation; the current state of the art.Experimental investigation of halogen-bond hard-soft acid-base complementarity.A quantitative approach to polar organic reactivity.A quantitative approach to nucleophilic organocatalysis.Control of the ambident reactivity of the nitrite ion.Ambident reactivities of formaldehyde N,N-dialkylhydrazones.A novel approach for the evaluation of positive cooperative guest binding: kinetic consequences of structural tightening.A facile synthesis of 3,4-dimercaptofurans via sulfenylation of (E)-β-chlorovinyl ketones and 1,2-sulfur migration.Bond Strength and Reactivity Scales for Lewis Superacid Adducts: A Comparative Study with In(OTf)3 and Al(OTf)3.Halogen Bonding in Organic Synthesis and Organocatalysis.Catalytic enantioselective synthesis of indanes by a cation-directed 5-endo-trig cyclization.Herbert Mayr.Cu(OAc)2-Et3N mediated oxidative coupling of α-azido ketones with pyridinium ylides: utilizing in situ generated imines for regioselective synthesis of imidazo[1,2-a]pyridines.The generalized maximum hardness principle revisited and applied to atoms and molecules.The fundamental flaw of the HSAB principle is revealed by a complete speciation analysis of the [PtCl(6-n)Br(n)](2-) (n = 0-6) system.Mechanistic investigation of aziridine aldehyde-driven peptide macrocyclization: the imidoanhydride pathway.Cationic Gold- and Silver-Catalyzed Cycloisomerizations of Propargylic Ureas: A Selective Entry to Oxazolidin-2-imines and Imidazolidin-2-ones
P2860
Q28817848-5D9BBED6-93FB-48C0-A34C-9A000F107B4CQ30659071-D08B6B34-C50B-4414-9178-57A041581A97Q33814132-FE1E4E5E-4A37-4BB4-A14F-6C7CD255B259Q34279129-7F08E724-B520-4896-B992-AC40B0DA5283Q35664642-6653D83D-82E1-489B-A556-D13B81CF99F7Q35874868-05C4C4D9-5C34-4079-B273-353DB0816D31Q36404750-8090E657-88C6-4A61-978E-7016B73CEB4FQ38001300-37A538E8-0B27-42F5-90A3-64F2F6CFDC47Q38008280-EE8904DC-5A50-4386-BF75-190982DBFCF6Q38238441-B486153B-FA95-4536-AE82-205DC210393BQ38864955-1EC0B23A-F448-4C3E-92B2-7B6DF035E474Q40598451-DEA142AF-F88D-40F0-A2FC-ADCD16D1C459Q42084604-570C7017-343E-4324-BC72-746E4EE32B3BQ43875742-CFA0AD99-A52B-4AD7-8265-753C9E46F62AQ44765712-BBFE8971-70BF-4950-BD59-9A0C61787CACQ45106272-208DA72B-41E8-41B2-BB4B-FD91AC40BC1CQ46421894-4096A0B0-1D5D-4A9B-BA47-C52281993F9EQ48049555-45B84115-6675-4711-8748-84859A916DE9Q48139503-A9A6A003-E1C1-4617-AF50-7F697AB7DA5FQ48232377-81306377-D35B-475C-AE50-347915A7A53CQ48430563-85636E28-4D63-4006-BA34-A722FE84244AQ50271627-95A7F259-E709-407D-9033-254ED8B857E0Q53107566-6D554CDE-0FEE-4E49-A4F0-36D8C0D25D23Q53811495-01840734-1973-4116-98FE-31ED0EDC947FQ55292697-273081E9-15CD-4048-82CF-3D0885572777Q57551662-C08C088C-AFDF-4EB2-BD2B-B3B64C31B967
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Farewell to the HSAB treatment of ambident reactivity.
@en
Farewell to the HSAB treatment of ambident reactivity.
@nl
type
label
Farewell to the HSAB treatment of ambident reactivity.
@en
Farewell to the HSAB treatment of ambident reactivity.
@nl
prefLabel
Farewell to the HSAB treatment of ambident reactivity.
@en
Farewell to the HSAB treatment of ambident reactivity.
@nl
P2093
P2860
P356
P1476
Farewell to the HSAB treatment of ambident reactivity.
@en
P2093
Armin R Ofial
Herbert Mayr
Martin Breugst
P2860
P304
P356
10.1002/ANIE.201007100
P407
P577
2011-07-01T00:00:00Z